Bosch Berend Jan, Smits Saskia L, Haagmans Bart L
Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, the Netherlands.
Department of Viroscience, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.
Curr Opin Virol. 2014 Jun;6:55-60. doi: 10.1016/j.coviro.2014.03.011. Epub 2014 Apr 22.
Six coronaviruses, including the recently identified Middle East respiratory syndrome coronavirus, are known to target the human respiratory tract causing mild to severe disease. Their interaction with receptors expressed on cells located in the respiratory tract is an essential first step in the infection. Thus far three membrane ectopeptidases, dipeptidyl peptidase 4 (DPP4), angiotensin-converting enzyme 2 (ACE2) and aminopeptidase N (APN), have been identified as entry receptors for four human-infecting coronaviruses. Although the catalytic activity of the ACE2, APN, and DPP4 peptidases is not required for virus entry, co-expression of other host proteases allows efficient viral entry. In addition, evolutionary conservation of these receptors may permit interspecies transmissions. Because of the physiological function of these peptidase systems, pathogenic host responses may be potentially amplified and cause acute respiratory distress.
包括最近发现的中东呼吸综合征冠状病毒在内的六种冠状病毒,已知会侵袭人类呼吸道,引发从轻度到重度的疾病。它们与呼吸道中细胞所表达的受体相互作用,是感染过程中至关重要的第一步。迄今为止,三种膜外肽酶,即二肽基肽酶4(DPP4)、血管紧张素转换酶2(ACE2)和氨肽酶N(APN),已被确定为四种感染人类冠状病毒的进入受体。尽管病毒进入并不需要ACE2、APN和DPP4肽酶的催化活性,但其他宿主蛋白酶的共表达可使病毒有效进入。此外,这些受体的进化保守性可能允许跨物种传播。由于这些肽酶系统的生理功能,致病性宿主反应可能会被潜在放大,并导致急性呼吸窘迫。